Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00975013 · ClinicalTrials.gov registry record
Bone Loss After Laparoscopic Roux-en-Y Gastric Bypass
A clinical trial of Bone Loss and Bariatric Surgery, sponsored by Gundersen Lutheran Medical Foundation.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT00975013 is a study of Bone Loss and Bariatric Surgery that has completed, run by Gundersen Lutheran Medical Foundation. The registered enrollment target is 40 participants, below the 252-participant average among 16 other Bone Loss trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00975013, a study of Bone Loss and Bariatric Surgery, has completed, sponsored by Gundersen Lutheran Medical Foundation.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to assess changes bone mineral density and bone metabolism after laparoscopic Roux-en-Y gastric bypass surgery. The investigators hypothesize that weight loss after laparoscopic Roux-en-Y gastric bypass surgery will be associated with increased bone turnover, changes in bone metabolism, and loss of bone mass.
Conditions Studied
Study Locations (1)
Wisconsin
- Gundersen Lutheran Health System - La Crosse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00975013
The ClinicalTrials.gov registry entry for NCT00975013 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 252-participant average among 16 other Bone Loss trials with a reported enrollment target (84% lower). The listed sponsor is Gundersen Lutheran Medical Foundation, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Bone Loss appearing as the primary indexed condition, and to 0 interventions.
NCT00975013 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00975013 about?
NCT00975013 is a clinical study titled "Bone Loss After Laparoscopic Roux-en-Y Gastric Bypass". The objective of this study is to assess changes bone mineral density and bone metabolism after laparoscopic Roux-en-Y gastric bypass surgery. The investigators hypothesize that weight loss after laparoscopic Roux-en-Y gastric bypass surgery will be associated with increased bone turnover, changes i...
What is the current status of trial NCT00975013?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2007-04. Estimated completion is 2009-12.
What conditions does trial NCT00975013 study?
This clinical trial studies the following conditions: Bone Loss, Bariatric Surgery, Bone Density, Gastric Bypass.
Who is sponsoring clinical trial NCT00975013?
This trial is sponsored by Gundersen Lutheran Medical Foundation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00975013 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bone, Exercise, Alendronate, and Caloric Restriction
RECRUITING · Phase 4
-
Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk
RECRUITING
-
Bone in CKD Alkali Response (BICARb Pilot Trial)
RECRUITING · Phase 2
-
Ridge Augmentation Using Allograft Particles Hydrated With or Without Recombinant Human Platelet-Derived Growth Factor
RECRUITING · NA
-
Lutein, Zeaxathin, and Fish Oil Supplementation
RECRUITING · NA
-
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.